Ann Arbor Stage I Primary Mediastinal (Thymic) Large B-Cell Lymphoma

Clinical trial pipeline · Data from ClinicalTrials.gov

See which Ann Arbor Stage I Primary Mediastinal (Thymic) Large B-Cell Lymphoma trials you may qualify for

Total trials

Actively recruiting

Phase 3 trials

Completed

Trial phase breakdown

Trial status

Actively recruiting — 1 trial

RecruitingPhase 2

NCT04745949

PACIFIC: Primary Mediastinal Large B-cell Lymphoma Treated With Antibody Therapy, Checkpoint Inhibitor in Frontline With…

This phase II trial studies the effect of brentuximab vedotin and nivolumab alone and in combination with rituximab, cyclophosphamide, doxorubicin, and predniso…

United States31 participantsStarted 2021-05-10

Treatment: Brentuximab Vedotin, Cyclophosphamide

All recent trials (3 shown)

Active — Not RecruitingPhase 1/2

NCT05025800

ALX148, Rituximab and Lenalidomide for the Treatment of Indolent and Aggressive B-cell Non-Hodgkin Lymphoma

This phase I/II trial finds out the best dose, possible benefits and/or side effects of ALX148 in combination with rituximab and lenalidomide in treating patien…

United States47 participantsStarted 2021-10-13

Treatment: CD47 Antagonist ALX148, Lenalidomide

Active — Not RecruitingPhase 2

NCT03749018

Nivolumab With DA-REPOCH Chemotherapy Regimen in Treating Patients With Aggressive B-Cell Non-Hodgkin's Lymphoma

This phase II trial studies how well nivolumab works with the DA-REPOCH chemotherapy regimen in treating patients with aggressive B-cell non-Hodgkin lymphoma. I…

United States30 participantsStarted 2019-01-02

Treatment: Cyclophosphamide, Doxorubicin Hydrochloride